Valganciclovir hydrochloride is a decree anesthetic accustomed by the U.S. Food and Drug Administration (FDA) for the analysis of cytomegalovirus retinitis (a viral Infection and deepening of the eye’s retina) in adults with AIDS. Valganciclovir hydrochloride is aswell FDA accustomed for the blockage of cytomegalovirus (CMV) ache in assertive displace recipients at top accident for developing CMV diseases.
CMV diseases, including CMV retinitis, are adept infections. An adept infection is an infection that occurs added frequently or is added astringent in humans with attenuated allowed systems—such as those adulterated with HIV—than in humans with advantageous allowed systems. To apprentice added about adept infections, apprehend the AIDSinfo What is an Adept Infection? actuality sheet.
Valganciclovir hydrochloride can aswell be used “off-label” to anticipate and amusement added adept infections of HIV infection. “Off-label” use refers to use of an FDA-approved anesthetic in a address altered from that declared on the anesthetic label. Good medical convenance and the best interests of a accommodating sometimes crave that a anesthetic be used “off-label.”